First COVID-19 patient to undergo plasma therapy in Maharashtra dies

National
Typography

The first Covid-19 patient who underwent convalescent plasma therapy in Maharashtra succumbed to the infection on Wednesday night at Lilavati Hospital, four days after he received the transfusion.

 

The 53-year-old male patient was in critical condition and had been under ventilation in the intensive care unit (ICU).

As per the report, he suffered from septicaemia and acute respiratory distress syndrome. The patient was admitted on April 20, by when his condition was critical and he required ventilator support. 

According to the doctors from the hospital, despite having symptoms like sore throat, dry cough and fever, he delayed his treatment thinking that he could not have contracted the disease since he didn’t have any travel history and also not a high-risk contact of any Covid-19 positive patient.

On Tuesday, Maharashtra Health Minister Rajesh Tope had said that plasma therapy is being used in the state on an experimental basis after getting approval from Indian Council of Medical Research (ICMR).

The therapy involves transfusing plasma – a component of the blood from a recovered patient into a patient fighting the infection. In theory, the antibodies of the recovered person may help that patient’s immune system fight the virus. 

Cautioning about the risks of using plasma therapy, ICMR had noted that convalescent plasma therapy comes with its own share of technical challenges, like antibody titer testing. There are also several risks of using this therapy including life-threatening allergic reactions and lung injury.

 

With inputs from Agency

Image: Representative purpose

 

All Comments